Accredited Activity

Overview

While there is no cure yet for diabetic retinopathy (DR), the best outcomes are in patients who are referred early for vision screening and treatment. Making sure patients with diabetes are following the recommended screening guidelines can help identify DR in its earliest stages and lead to earlier treatment to help preserve vision. Join Dr Vivian Fonseca as he discusses DR and how to educate patients on the importance of regular vision screenings.

Target Audience

This activity has been designed to address the educational needs of PCPs (ie, internists, family practitioners, nurse practitioners, and PAs), endocrinologists, optometrists, ophthalmologists, and residents.

Accredited Providers and Collaborating Partners

This activity is provided by Paradigm Medical Communications, LLC.

Supporter Acknowledgment

Learning Objectives

Upon completion of this activity, participants should be able to:

• Describe the natural history of DR/diabetic macular edema (DME), with an emphasis on the progressive nature, which underscores the need for earlier diagnosis and treatment to prevent the development of vision-threatening complications

Faculty & Disclosures

Presenting Faculty

Vivian Fonseca, MD

Professor of Medicine and Pharmacology

Assistant Dean for Clinical Research

Tullis Tulane Alumni Chair in Diabetes

Chief, Section of Endocrinology

Tulane University Health Sciences Center

New Orleans, LA

Steering Committee

Judy E. Kim, MD, FARVO, FASRS—Chairperson

Professor, Ophthalmology and Visual Sciences

Vitreoretinal Diseases and Surgery

Professor, Graduate School of Biomedical Sciences

Director, Teleophthalmology and Research

Medical College of Wisconsin

Milwaukee, WI

Vivian Fonseca, MD

Professor of Medicine and Pharmacology

Assistant Dean for Clinical Research

Tullis Tulane Alumni Chair in Diabetes

Chief, Section of Endocrinology

Tulane University Health Sciences Center

New Orleans, LA

Amy Zack, MD

Faculty Reviewers

Justine Filippelli, MS, PA-C

Physician Assistant, Oculoplastic and Reconstructive Surgery

Cole Eye Institute

Cleveland, OH

Debbie Hinnen, APN, BC-ADM, CDCES, FAAN

Advanced Practice Nurse

Certified Diabetes Care and Education Specialist

University of Colorado Health

Colorado Springs, CO

Disclosure of Relevant Financial Relationships

In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Paradigm requires that all planners, faculty, and others who are in a position to control the content of this activity disclose all financial relationships with ineligible companies during the past 24 months.

All relevant relationships are identified and mitigated according to Paradigm policy prior to individuals assuming their roles, and are disclosed prior to learners’ engagement in the activity. Paradigm is committed to providing learners with high-quality accredited continuing education that promotes improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The content of this activity was independently reviewed to ensure that it is fair and balanced, scientifically rigorous, evidence based, and aligned with the public interest. All relevant relationships have been mitigated.

Justine Filippelli, PA-C

Has no relevant financial relationships with ineligible companies to disclose.

Vivian Fonseca, MD

Consultant: Abbott; Asahi Kasei Pharma Corporation; AstraZeneca; Bayer Corporation; Novo Nordisk A/S; Sanofi

Speakers Bureau: Abbott; Bayer Corporation; Asahi Kasei Pharma Corporation; AstraZeneca; Novo Nordisk A/S; Sanofi

Research Funding: Fractyl Health, Inc; Jaguar Gene Therapy (paid to Tulane)

Stock/Stock Options: Abbott; Amgen Inc; BRAVO4Health; Mellitus Health, Inc

Royalties/Patent Beneficiary: BRAVO Risk Engine (patent pending)

Debbie Hinnen  APN, BC-ADM, CDCES, FAAN

Advisor: Boehringer Ingelheim International GmbH; Eli Lilly and Company; Intuity Medical, Inc; Novo Nordisk A/S; Sanofi

Consultant: Boehringer Ingelheim International GmbH; Eli Lilly and Company; Novo Nordisk A/S; Sanofi

Speakers Bureau: Boehringer Ingelheim International GmbH; Eli Lilly and Company; Novo Nordisk A/S; Sanofi (expired 2021)

Judy E. Kim, MD, FARVO, FASRS, MD—Chairperson

Advisor: Novartis AG

Consultant: Adverum Biotechnologies, Inc; Allergan, Inc.; Alimera Sciences; Dutch Ophthalmic Research Center (International) BV;  Genentech, Inc.; Novartis AG; Regeneron Pharmaceuticals Inc

Research Funding: Notal Vision, Inc; Heidelberg Engineering, Inc; Optos

Amy Zack, MD

Has no relevant financial relationships with ineligible companies to disclose

Michelle Dalton

Independent Contractor: Allergan, Inc.; ZEISS International; Heidelberg Engineering Inc (expired 2021); Notal Vision, Inc (expired 2021); NovaSight; OcularTherapeutix, Inc (expired 2020); Tarsius Pharma

Stocks: Abbvie Inc. (sold 1/22); Bristol-Myers Squibb Company (sold 1/22); Johnson & Johnson Services, Inc

Staff planners from American Association of Nurse Practitioners, American Academy of Physician Associates, California Academy of Family Physicians, Paradigm Medical Communications, LLC, Endocrine Society, Global Education Group, and Salus University Pennsylvania College of Optometry not listed above have no relevant financial relationships with ineligible companies to disclose.

Independent peer reviewer has no relevant financial relationships with ineligible companies to disclose.

CE Information

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation Statement

Paradigm Medical Communications, LLC designates this enduring activity for a maximum of 0.25 AMA PRA  Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed Credit

Optometrist Continuing Education

AAPA Credit Designation Statement

his activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation. Approval is valid through May 31, 2023.

AANP Credit Designation Statement

This activity is approved for 0.25 contact hour of continuing education by the American Association of Nurse Practitioners®. Activity ID# 22095802. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.

Disclaimer

This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

As an ACCME-accredited provider, Paradigm Medical Communications, LLC must ensure that its activities include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.

Terms of Use and Privacy Policy

Disclaimer

The materials provided for this activity are for informational purposes only and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.

Privacy policy

Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information

This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of your personal information

The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.

Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

Contact Us

If you have any questions or comments, please email us at contactus@paradigmmc.com.

© 2022 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.